Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abiomed Inc 22 CHERRY HILL DR DANVERS MA 01923 USA

P: 978-646-1400 F: 978-777-8411

Description:

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company'sproducts are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Key Statistics

Overview:

Market Capitalization, $K 15,313,908
Shares Outstanding, K 45,086
Annual Sales, $ 593,750 K
Annual Net Income, $ 112,170 K
Last Quarter Sales, $ 200,560 K
Last Quarter Net Income, $ 44,860 K
60-Month Beta 0.37
% of Insider Shareholders 3.50%
% of Institutional Shareholders 86.80%
Float, K 43,508
% Float 96.50%

Growth:

1-Year Return 15.44%
3-Year Return 274.90%
5-Year Return 1,221.63%
5-Year Revenue Growth 275.51%
5-Year Earnings Growth 562.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.97 on 01/31/19
Next Earnings Date 05/02/19
Earnings Per Share ttm 3.36
EPS Growth vs. Prev Qtr 19.75%
EPS Growth vs. Prev Year 38.57%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 10/02/00

ABMD Ratios

Ratio
Price/Earnings ttm 101.00
Price/Earnings forward 123.10
Price/Earnings to Growth 3.42
Return-on-Equity (After Tax) 20.31
Return-on-Assets (Before Tax) 18.03
Net Margin % -9.74
Debt/Equity 0.00
Price/Sales 25.77
Price/Cash Flow 122.00
Price/Book 17.95
Book Value/Share 18.91
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar